Fentanyl or Esketamine for Traumatic PAIN (FORE-PAIN) Trial

Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

About this trial

Fentanyl and esketamine are both standard of care for treatment of acute severe traumatic pain in the prehospital setting in the Netherlands. However, it is not known whether they are equally effective and safe. It is also not known whether intranasal (IN) administration of fentanyl or esketamine is equally effective and safe as intravenous (IV) administration.

The FORE-PAIN trial is a double-blind multi-arm randomized non-inferiority trial comparing Fentanyl IN, esketamine IV and esketamine IN (intervention arms) to fentanyl IV (comparator arm) for prehospital management of traumatic pain. The investigators hypothesize that all intervention arms provide analgesia that is non-inferior to the comparator arm, and that all study arms are equally safe.

Eligibility criteria

Qualifiers

age ≥ 18 years

pain has been caused by a trauma (any trauma mechanism) that occurred on the same day

Emergency Medical Services personnel determines that administration of a strong opioid or esketamine for analgesia is required

patient will be transported to a hospital

Disqualifiers

(estimated) weight <40 or >100 kg

subject does not understand Dutch or English

inability to report pain score

inability to give IN or IV medication

Trial design

Treatments tested in this trial

  • Fentanyl Citrate
  • Esketamine

Treatment groups

608 Participants
are divided into 4 treatment groups

Sponsors and collaborators

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Lead sponsor

Stichting ZiektekostenVerzekering Krijgsmacht

Collaborator

Ambulance Amsterdam

Collaborator